Factory Supply Valsartan Sacubitril Powder CAS 936623-90-4 Valsartan Sacubitril for Pharmaceutical Intermediate

Min.Order: 1
Product origin: Xi'an, Shaanxi, China
Infringement complaint: complaintComplaint
US$ 15 ~ 30

Description

                   

Factory Supply Valsartan Sacubitril Powder CAS 936623-90-4 Valsartan Sacubitril  For Pharmaceutical Intermediate
 
Product NameFactory Supply Valsartan Sacubitril Powder CAS 936623-90-4 Valsartan Sacubitril  For Pharmaceutical Intermediate
Appearancepowder
cas936623-90-4
Assay99%
KeywordsValsartan Sacubitril;Valsartan Sacubitril Powder;Valsartan Sacubitril CAS 936623-90-4
Shelf Life24 months when properly stored
StorageKeep in a cool, dry, dark location
 
What is Valsartan Sacubitril?

LCZ696 is a dual angiotensin II receptor antagonist and neprilysin inhibitor that is a combination of the nonpeptide angiotensin II receptor antagonist valsartan (Item No. 14178) and AHU377 (Item No. 21473), a prodrug of LBQ657 (Item No. 19829), which is an inhibitor of the zinc metallopeptidase neprilysin., LCZ696 (2-60 mg/kg) induces a dose-dependent decrease in mean arterial pressure in rats expressing human renin and angiotensinogen, a double-transgenic model for angiotensin II-dependent hypertension. Formulations containing LCZ696 are under clinical investigation for the treatment of mild to moderate hypertension and chronic heart failure.

 

Function of Valsartan Sacubitril
 
LCZ696, a first-in-class inhibitor of dualacting angiotensin-2 type-I receptor and neprilysin inhibitors, was developed as a molecule composed of molecular moieties of valsartan and neprilysin inhibitor prodrug AHU377 in a 1:1 ratio. Several phase 2 randomised clinical trials have been done or are underway in patients with hypertension. In a proof-of-concept randomised trial, LCZ696 was compared with valsartan in 1328 patients with mild-to-moderate hypertension, and provided fully additive reduction of blood pressure. No cases of angio-oedema were reported in the 8 week treatment period. This tolerance should be confirmed, particularly in black patients, for whom omapatrilat resulted in a higher occurrence of angio-oedema than in white patients. Indeed, in the proof-of-concept trial only about 8% of patients were black.

Pharmaceutical API Anti Heart Failure Raw Powder CAS 936623-90-4 LCZ696 
 
                                                                                                                               »»» CLICK HERE TO SEE MORE STOCK
 Veterinary Medicine Raw Materials, Veterinary Raw Material, Veterinary Active Pharmaceutical, Powder Raw Material Supplier
Powder Raw Material Manufacturer, Powder Raw Material FactoryVeterinary Medicine Raw Materials, Veterinary Raw Material, Veterinary Active Pharmaceutical, Powder Raw Material Supplier
Powder Raw Material Manufacturer, Powder Raw Material Factory

Q: What's your MOQ ?

A: For the high value product, our MOQ starts from 1g and generally starts from 10gs. For other low, price product, our MOQ starts from 100g and 1kg.

 
Q: Is there a discount ?
A: Yes, for larger quantity, we always support with better price.
 
Q: How to confirm the Product Quality before placing orders ?
A: You can get free samples for some proucts, you only need to pay the shipping cost or arrange a courier to us and take the samples. You can send us your product specifications and requests, we will manufacture the products according to your requests.
 
Q: How to start orders or make payments ?
A: You can send our your Purchase order ( if your company has ), or just send a simple confirmation by email or by Trade Manager, and we will send you Proforma Invoice with our bank details for your confirmation, then you can make payment accordingly.
 
Q: How do you treat quality complaint ?
A: First of all, our quality control will reduce the quality problem to near zero. If there is a quality problem caused by us, we will send you free goods for replacement or refund your loss.

Pharmaceutical API Anti Heart Failure Raw Powder CAS 936623-90-4 LCZ696 
Product Tag:
Related categories:
Scroll to Top